Clinical trial
Combination Chemotherapy in Treating Patients With Advanced Cancer
NCT00021073 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00021073 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Advanced Cancer |
| Official title | Phase I Study of Flavopiridol in Combination With 5-Fluorouracil, Leucovorin and Irinotecan in Patients With Advanced Malignancies |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | alvocidib, leucovorin calcium, fluorouracil, irinotecan hydrochloride |
| Enrollment | 90 |
| Start date | May 1, 2001 |
| Primary completion | Apr 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: